PSMD1 and COVID-19: 68 donors naïve for SARS-CoV-2 (SARS-CoV-2-negative) and 62 COVID-19 convalescent participants (SARS-CoV-2-exposed) were investigated for T cell reactivity against the SARS-CoV-2 antigens S1 and NP.